FLOREANI, ANNAROSA
 Distribuzione geografica
Continente #
NA - Nord America 21.466
AS - Asia 3.271
EU - Europa 2.605
SA - Sud America 97
AF - Africa 64
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 6
Totale 27.519
Nazione #
US - Stati Uniti d'America 21.443
SG - Singapore 1.692
CN - Cina 1.119
IT - Italia 539
FI - Finlandia 455
DE - Germania 406
SE - Svezia 278
UA - Ucraina 231
HK - Hong Kong 203
FR - Francia 201
GB - Regno Unito 183
VN - Vietnam 162
RU - Federazione Russa 151
BR - Brasile 84
CI - Costa d'Avorio 51
IE - Irlanda 45
NL - Olanda 38
IN - India 35
AT - Austria 18
ES - Italia 13
JP - Giappone 13
CA - Canada 12
MX - Messico 8
PK - Pakistan 8
AU - Australia 7
IQ - Iraq 7
BG - Bulgaria 6
EU - Europa 6
GR - Grecia 6
PL - Polonia 6
CH - Svizzera 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
MA - Marocco 4
UZ - Uzbekistan 4
IR - Iran 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PE - Perù 3
PH - Filippine 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
KE - Kenya 2
KR - Corea 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
TR - Turchia 2
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BE - Belgio 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 27.519
Città #
Fairfield 3.474
Woodbridge 2.251
Houston 1.801
Ann Arbor 1.590
Ashburn 1.484
Chandler 1.398
Wilmington 1.287
Seattle 1.262
Cambridge 1.204
Jacksonville 1.105
Singapore 761
Princeton 500
Boardman 492
San Diego 360
Santa Clara 345
Beijing 295
Medford 241
Nanjing 203
Hong Kong 202
Des Moines 183
Padova 178
Roxbury 177
Helsinki 163
Dong Ket 160
Guangzhou 62
Hebei 54
Shenyang 53
London 52
Abidjan 51
Nanchang 50
Norwalk 50
New York 48
Dublin 45
Jiaxing 45
Falls Church 40
Redwood City 34
Changsha 33
Tianjin 33
Nuremberg 25
Kharkiv 20
Jinan 19
Rome 19
Shanghai 19
Dallas 18
Milan 18
Amsterdam 16
Los Angeles 16
Ogden 16
Treviso 14
Bergamo 13
Borås 13
Vienna 13
Salerno 12
Hounslow 11
Kilburn 11
Indiana 10
Nürnberg 10
Rockville 10
Washington 10
Chicago 9
Detroit 9
Falkenstein 9
Dearborn 8
Ningbo 8
Origgio 8
Taizhou 8
Kunming 7
Munich 7
Naples 7
Taiyuan 7
Tappahannock 7
Zhengzhou 7
Haikou 6
Sofia 6
A Coruña 5
Chiswick 5
Hirakata 5
Leeds 5
Marostica 5
Phoenix 5
Verona 5
Acton 4
Boston 4
Council Bluffs 4
Hefei 4
Montecorvino Rovella 4
New Bedfont 4
Prescot 4
Pune 4
Redmond 4
Sahiwal 4
Tashkent 4
Tokyo 4
Toronto 4
Venice 4
Vicenza 4
Aix-en-Provence 3
Athens 3
Auckland 3
Baghdad 3
Totale 22.299
Nome #
Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis 166
Primary biliary cirrhosis: overlaps with other autoimmune disorders 157
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. 149
Heparanase and macrophage interplay in the onset of liver fibrosis 148
Extrahepatic autoimmunity in autoimmune liver disease 147
Coronary flow reserve in patients with primary biliary cholangitis 146
The efficacy of adalimumab in psoriatic arthritis concomitant to overlapping primary biliary cholangitis and primary sclerosing cholangitis: a case report 143
Hepatitis C virus eradication with direct acting antiviral improves insulin resistance 142
Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis 140
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 140
Metabolic Syndrome Associated With Primary Biliary Cirrhosis. 139
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis 139
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study 134
Is osteopenia a peculiar association with primary biliary cirrhosis (PBC)? 133
Extrahepatic Malignancies in Primary Biliary Cirrhosis: A Comparative Study at Two European Centers. 132
Thyroid Dysfunction in Primary Biliary Cholangitis: A Comparative Study at Two European Centers 131
Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis 131
Hepatitis A and hepatitis B virus infection in children and adolescents in north-east Italy. 130
Is adiponectin a potential protective factor against atherosclerosis in primary biliary cirrhosis (PBC)? 130
Acute hepatitis in elderly patients. 128
Western Diet-Induced Metabolic Alterations Affect Circulating Markers of Liver Function before the Development of Steatosis 128
Functional differentiation of human pluripotent stem cells on a chip 124
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis. 124
The administration of a high-fat diet alters bile acid composition and hepatic drug metabolism in rats 124
Ursodeoxycholic Acid Therapy and Liver Transplant-free Survival in Patients with Primary Biliary Cholangitis 124
Viral load in HCV RNA-positive pregnant women. 121
Hepatitis C virus infection in pregnancy. 119
Functional differentiation of human pluripotent stem cells on a chip. 118
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre. 118
Effects of Age and Sex of on Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis 118
Preventative therapy in primary biliary cirrhosis 117
A new non-invasive technique in primary sclerosing cholangitis (PSC): A case-control study 117
Are homes for the elderly still a risk area for HBV infection? 117
Colchicine in chronic hepatitis B: a pilot study 116
A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis. 115
Bone metabolism in male subjects undergoing liver transplantation (OLTx) 115
Longitudinal study on osteodystrophy in primary biliary cirrhosis (PBC) and a pilot study on calcitonin treatment. 115
BRIC AUTOSOMAL DOMINANT BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS (BRIC) UNLINKED TO 18Q 21 LOCUS: IS IT A NEW ENTITY? 114
P.16.3 THE PROGNOSTIC ROLE OF MAGNETIC RESONANCE CHOLANGIOGRAPHY IN PSC 113
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region 113
Anti-hepatitis C virus in the elderly: a seroepidemiological study in a home for the aged. 113
Plasma Adiponectin Levels in Primary Biliary Cirrhosis: A Novel Perspective for Link Between Hypercholesterolemia and Protection Against Atherosclerosis 113
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a Southern European population 112
THE EARLY DIAGNOSIS IMPROVES SURVIVAL IN PRIMARY BILIARY CIRRHOSIS: A 35-YEAR FOLLOW-UP IN A SINGLE CENTRE 112
Familial primary biliary cirrhosis and autoimmune cholangitis 111
Intron 2 [IVS2, T-C +4] HFE gene mutation associated with S65C causes alternative RNA splicing and is responsible for iron overload 111
Follow-up magnetic resonance imaging/3D-magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret 111
In vitro metabolic zonation through oxygen gradient on a chip 111
Bone metabolism in orthotopic liver transplantation: a prospective study. 110
Type 1 autoimmune hepatitis: Clinical course and outcome in an Italian multicentre study 110
Pregnane X receptor and constitutive androstane receptor modulate differently CYP3A-mediated metabolism in earlyand late-stage cholestasis 110
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 110
MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18–60 years of age) with chronic diseases who are at risk of post-influenza complications 109
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection. 109
HEPATOCELLULAR PROLIFERATION, TNF-ALPHA AND INFLAMMATION IN PRIMARY BILIARY-CIRRHOSIS (PBC) 109
Gender medicine: a task for the third millennium. 109
AISF position paper on liver disease and pregnancy 109
Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis. 109
PERFORMANCE OF SURROGATE MARKERS OF HEPATIC FIBROSIS IN PRIMARY BILIARY CIRRHOSIS 108
Primary biliary cirrhosis: report of a focus study group. 107
Liver transplantation and pregnancy. 107
Hepatitis C and pregnancy 107
A 3-year pilot study with 1,25-dihydroxyvitamin D, calcium, and calcitonin for severe osteodystrophy in primary biliary cirrhosis. 107
Primary biliary cholangitis: Old and novel therapy 107
Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation 107
Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C 106
Lack of increased frequency of the CC chemokine receptor 5-DELTA32/DELTA32 genotype in Hepatitis C 106
Performance and utility of transient elastography and noninvasive markers of liver fibrosis in primary biliary cirrhosis. 106
Bone metabolism in male subjects undergoing liver transplantation (OLTx) 106
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. 105
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 105
Y chromosome loss in male patients with primary biliary cirrhosis 104
Morning bright light treatment for sleep-wake disturbances in primary biliary cholangitis: A pilot study 104
A new non-invasive technique in primary sclerosing cholangitis (PSC): A case-control study 103
Fatal hepatic decompensation in a bone marrow transplant recipient with HBV-related cirrhosis following lamivudine withdrawal. 103
Platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices: results of a multicenter, prospective, validation study. 103
An open population screening study for HFE gene major mutations proves the low prevalence of C282Y mutation in Central Italy 103
Activation of the IGF1 system characterizes cholangiocyte survival duringprogression of primary biliary cirrhosis. 103
Retreatment of patients with chronic hepatitis C relapsers to a previous antiviral treatment. 103
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 102
Hepatic Methionine-enkephalin may interfere with response to antiviral therapy in chronic hepatitis C 102
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 102
''Plasma antioxidant levels in chronic cholestatic liver diseases'' 100
The activation of NF-kB, Pregnane X Receptor, and Constitutive Androstane Receptor is modulated by the degree of cholestasis 99
New therapies for primary biliary cirrhosis 99
Response to influenza vaccine in people with non-protective HI antibody titers. 98
Primary biliary cirrhosis and hepatitis C virus infection 98
Incidence of hepatic and extra-hepatic malignancies in primary biliary cirrhosis (PBC). 98
Prevalence of familial disease in primary biliary cirrhosis in Italy 98
New Insights on Intrahepatic Cholestasis of Pregnancy 98
Hepatobiliary phospholipid transporter ABCB4, MDR3 gene variants in a large cohort of Italian women with intrahepatic cholestasis of pregnancy. 97
Occupational risk of blood-borne viruses in healthcare workers: a 5-year surveillance program. 97
Cytokine, infiltrating macrophage and T cell-mediated response to development of primary and secondary human liver cancer. 97
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 97
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient Survival 96
Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations 95
Cysteine and glutathione in the liver of patients with primary biliary cirrhosis. 95
Assessing patients' understanding of hepatitis C virus infection and its impact on their lifestyle 95
TTV infection in patients with acute hepatitis of defined aetiology and in acute non-A-E hepatitis 95
Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis. 95
Totale 11.426
Categoria #
all - tutte 109.788
article - articoli 100.260
book - libri 344
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.110
Totale 213.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.090 0 0 0 0 0 0 0 0 0 544 291 255
2020/20213.449 152 261 236 360 121 220 85 361 501 368 478 306
2021/20224.500 129 525 668 280 225 264 250 481 187 90 476 925
2022/20233.083 681 273 53 328 504 437 47 228 327 16 154 35
2023/20241.393 66 188 158 116 72 127 81 104 53 37 170 221
2024/20253.772 12 564 322 249 843 185 290 492 705 110 0 0
Totale 27.775